Assembling A New Gene Therapy Company To Develop The Next Generation Of Pioneering Medicines

By Christina Maat, Junior Technician at VectorY and Charlotte McLure, Junior Technician at VectorY

Despite the difficulties associated with start-ups and hurdles presented by the pandemic, Advance Biotech Grant Winner VectorY, an Amsterdam based gene therapy company, continues to make steps towards developing vectorized antibodies to treat diseases of high unmet medical need with a specific focus on muscle and neuromuscular disease. Continue reading to learn what makes VecorY stand out from the rest.